Kenvue's Q2 2025 earnings call highlights leadership changes, strategic reviews, and a revised guidance reflecting a low single-digit sales decline.

Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost ...

Kenvue forecast its annual profit below Wall Street estimates, as it undergoes a strategic review, which investors expect ...

Key Points Non-GAAP earnings per share of $0.29 in Q2 FY2025 beat expectations, but GAAP revenue missed estimates and GAAP net sales declined 4.0% from the prior year. Management lowered its FY2025 ...

The Summit, N.J., drugmaker said Monday that both net and organic sales are likely to be down by low single-digit percentages from last year. It previously guided for net sales to grow 1% to 3%, and ...

Kenvue Inc. shares fell 3.4% in premarket trading after the consumer health company reported second-quarter results that ...